Nils Carlin

1.5k total citations
38 papers, 1.2k citations indexed

About

Nils Carlin is a scholar working on Endocrinology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Nils Carlin has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, 20 papers in Infectious Diseases and 13 papers in Molecular Biology. Recurrent topics in Nils Carlin's work include Escherichia coli research studies (27 papers), Viral gastroenteritis research and epidemiology (19 papers) and Glycosylation and Glycoproteins Research (12 papers). Nils Carlin is often cited by papers focused on Escherichia coli research studies (27 papers), Viral gastroenteritis research and epidemiology (19 papers) and Glycosylation and Glycoproteins Research (12 papers). Nils Carlin collaborates with scholars based in Sweden, United States and France. Nils Carlin's co-authors include Alf A. Lindberg, Anna Lundgren, Jan Holmgren, Richard I. Walker, Ann‐Mari Svennerholm, David R. Bundle, Louis Bourgeois, John D. Clements, Joshua Tobias and Stefan B. Svenson and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Virology.

In The Last Decade

Nils Carlin

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nils Carlin Sweden	24	850	665	311	249	202	38	1.2k
Frederick J. Cassels United States	19	485 0.6×	429 0.6×	388 1.2×	116 0.5×	162 0.8×	37	1.2k
Cristina Alaimo Switzerland	16	356 0.4×	378 0.6×	346 1.1×	158 0.6×	76 0.4×	19	985
K Haider Bangladesh	19	791 0.9×	499 0.8×	273 0.9×	65 0.3×	295 1.5×	38	1.3k
S De Grandis Canada	9	591 0.7×	434 0.7×	169 0.5×	130 0.5×	164 0.8×	9	874
Chiayung Chu United States	17	621 0.7×	600 0.9×	278 0.9×	84 0.3×	215 1.1×	19	1.1k
João Ramos Costa Andrade Brazil	19	810 1.0×	555 0.8×	160 0.5×	58 0.2×	346 1.7×	32	1.1k
Alaullah Sheikh United States	25	686 0.8×	563 0.8×	238 0.8×	117 0.5×	399 2.0×	40	1.3k
Joanna Kübler-Kiełb United States	23	245 0.3×	221 0.3×	492 1.6×	171 0.7×	76 0.4×	43	1.2k
Dagmara Kisiela United States	19	431 0.5×	272 0.4×	347 1.1×	201 0.8×	257 1.3×	34	1.0k
Francesca Necchi Italy	21	404 0.5×	471 0.7×	292 0.9×	180 0.7×	243 1.2×	36	1.2k

Countries citing papers authored by Nils Carlin

Since Specialization

Citations

This map shows the geographic impact of Nils Carlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils Carlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils Carlin more than expected).

Fields of papers citing papers by Nils Carlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nils Carlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils Carlin. The network helps show where Nils Carlin may publish in the future.

Co-authorship network of co-authors of Nils Carlin

This figure shows the co-authorship network connecting the top 25 collaborators of Nils Carlin. A scholar is included among the top collaborators of Nils Carlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nils Carlin. Nils Carlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maier, Nicole, Shannon Grahek, Jane L. Halpern, et al.. (2023). Efficacy of an Enterotoxigenic Escherichia coli (ETEC) Vaccine on the Incidence and Severity of Traveler’s Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severity Score. Microorganisms. 11(10). 2414–2414. 5 indexed citations

Chilyabanyama, Obvious Nchimunya, Samuel Bosomprah, Nils Carlin, et al.. (2023). Safety, tolerability, and immunogenicity of an oral inactivated ETEC vaccine (ETVAX®) with dmLT adjuvant in healthy adults and children in Zambia: An age descending randomised, placebo-controlled trial. Vaccine. 41(46). 6884–6894. 10 indexed citations

Jokiranta, T. Sakari, Sari H. Pakkanen, Peter Klemets, et al.. (2023). Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic Escherichia coli diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa. Journal of Travel Medicine. 30(7). 21 indexed citations

Hossain, M. Jahangir, Ann‐Mari Svennerholm, Nils Carlin, Umberto D’Alessandro, & Thomas F. Wierzba. (2023). A Perspective on the Strategy for Advancing ETVAX®, An Anti-ETEC Diarrheal Disease Vaccine, into a Field Efficacy Trial in Gambian Children: Rationale, Challenges, Lessons Learned, and Future Directions. Microorganisms. 12(1). 90–90. 3 indexed citations

Qadri, Firdausi, Marjahan Akhtar, Taufiqur Rahman Bhuiyan, et al.. (2019). Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial. The Lancet Infectious Diseases. 20(2). 208–219. 88 indexed citations

Leach, Susannah, et al.. (2017). Cross-reactivity and avidity of antibody responses induced in humans by the oral inactivated multivalent enterotoxigenicEscherichia coli (ETEC) vaccine ETVAX. Vaccine. 35(32). 3966–3973. 36 indexed citations

Tang, Swee-Seong, Nils Carlin, Kaisar A. Talukder, Phung Dac Cam, & Naresh K. Verma. (2016). Shigella flexneri serotype 1c derived from serotype 1a by acquisition of gtrIC gene cluster via a bacteriophage. BMC Microbiology. 16(1). 127–127. 5 indexed citations

Borde, Annika, et al.. (2016). Preparation and preclinical evaluation of a freeze-dried formulation of a novel combined multivalent whole-cell/B-subunit oral vaccine against enterotoxigenic Escherichia coli diarrhea. European Journal of Pharmaceutics and Biopharmaceutics. 108. 18–24. 8 indexed citations

Lundgren, Anna, Louis Bourgeois, Nils Carlin, et al.. (2014). Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study. Vaccine. 32(52). 7077–7084. 104 indexed citations

10.

Holmgren, Jan, Louis Bourgeois, Nils Carlin, et al.. (2013). Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant. Vaccine. 31(20). 2457–2464. 107 indexed citations

11.

Lundgren, Anna, Susannah Leach, Joshua Tobias, et al.. (2013). Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein. Vaccine. 31(8). 1163–1170. 44 indexed citations

12.

Tobias, Joshua, Ann‐Mari Svennerholm, Nils Carlin, Michael Lebens, & Jan Holmgren. (2011). Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice. Vaccine. 29(48). 8863–8869. 24 indexed citations

13.

Carlin, Nils, et al.. (2011). Structural elucidation of the O-antigen of the Shigella flexneri provisional serotype 88-893: structural and serological similarities with S. flexneri provisional serotype Y394 (1c). Carbohydrate Research. 346(6). 872–876. 26 indexed citations

14.

Tang, Swee-Seong, et al.. (2009). A Novel Glucosyltransferase Involved in O-Antigen Modification of Shigella flexneri Serotype 1c. Journal of Bacteriology. 191(21). 6612–6617. 44 indexed citations

15.

Boberg, Andreas, Stefan Gaunitz, Andreas Bråve, Britta Wahrén, & Nils Carlin. (2008). Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin. Vaccine. 26(40). 5079–5082. 11 indexed citations

16.

Freiberg, Alexander N., Renato Morona, Luisa Van Den Bosch, et al.. (2003). The Tailspike Protein of Shigella Phage Sf6. Journal of Biological Chemistry. 278(3). 1542–1548. 47 indexed citations

17.

Morona, Renato, et al.. (1995). Lipopolysaccharide with an altered O‐antigen produced in Escherichia coli K‐12 harbouring mutated, cloned Shigella flexneri rfb genes. Molecular Microbiology. 18(2). 209–223. 32 indexed citations

18.

Carlin, Nils, et al.. (1988). Structural and immunochemical studies of the lipopolysaccharide from a new provisional serotype of Shigella flexneri. European Journal of Biochemistry. 176(2). 471–476. 29 indexed citations

19.

Carlin, Nils & Alf A. Lindberg. (1987). Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type IV, V, and VI antigens, group 3,4 antigen, and an epitope common to all Shigella flexneri and Shigella dysenteriae type 1 stains. Infection and Immunity. 55(6). 1412–1420. 58 indexed citations

20.

Carlin, Nils, et al.. (1985). Production and characterization of KDO-specific monoclonal antibodies recognizing lipopolysaccharides from heptoseless mutants ofSalmonella. FEMS Microbiology Letters. 28(1). 45–49. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact